Market Place
Sourcing Support
Morepen Laboratories appoints Amrit Ravi as Vice President
01 Oct 2024 //
INDPHARMAPOST
Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr
02 Feb 2024 //
INDIAN PHARMA POST
Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr
03 Nov 2023 //
INDIAN PHARMA POST
Morepen gets US FDA approval for Fexofinadine
03 Dec 2021 //
EXPRESSPHARMA
Morepen Labs approves transfer of POC medical devices to wholly-owned subsidiary
02 Sep 2021 //
PHARMABIZ
RDIF & Morepen Lab announce production of the test batch of Sputnik V in India
06 Jul 2021 //
BIOSPECTRUMINDIA
India`s Morepen Labs starts production of test batch of Sputnik V vaccine
06 Jul 2021 //
ECONOMIC TIMES
Morepen Lab gets license to manufacture HCQ in Baddi plant; stock up 10%
21 Apr 2020 //
INDIAINFOLINE
Morepen Labs shares surge 8% on license to manufacture Hydroxychloroquine
20 Apr 2020 //
MONEYCONTROL
Morepen Labs introduces three new API drugs
15 Oct 2019 //
PHARMABIZ
Morepen Labs gets USFDA nod for asthma drug
21 Dec 2017 //
ECONOMIC TIMES
Morepen surges 18% on USFDA clearance for anti-asthmatic drug Montelukast
20 Dec 2017 //
BUSINESS-STANDARD
Morepen Labs net profit up by 24% to Rs.10.37 crore in Q2
13 Nov 2017 //
PHARMABIZ
Exports major contributor to API revenues: Sushil Suri, Morepen Labs
02 May 2017 //
ECONOMIC TIMES
Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap
27 Feb 2017 //
BUSINESS STANDARD
Pinfold Overseas acquires 6.42 stake in Morepen Laboratories
01 Dec 2016 //
ECONOMIC TIMES
Morepen to sell anti-asthmatic drug Montelukast in Europe, North America
09 Feb 2016 //
ECONOMIC TIMES
Morepen Laboratories hits 52-week high on good Q2 results
04 Nov 2015 //
BUSINESS STANDARD
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.